22 min listen
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
ratings:
Length:
63 minutes
Released:
Nov 29, 2023
Format:
Podcast episode
Description
Dr Aditya Bardia from Massachusetts General Hospital and Dr Sara M Tolaney from the Dana-Farber Cancer Institute, both in Boston, Massachusetts, discuss key presentations on the management of breast cancer from the 2023 ESMO Congress, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Breast).
CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Breast).
Released:
Nov 29, 2023
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love